Vivus Wins Its First Fda Drug Approval

The FDA approved a drug to treat erectile dysfunction from Vivus that would compete against Viagra, Cialis and Levitra.

Topics:  fda   vivus   viagra   cialis   levitra   drug   
BING NEWS:
  • Orexigen Investors Can Get Litigation Insight From Vivus
    Orexigen (NASDAQ:OREX) investors got a bit of bad news this week, when Actavis Laboratories (NYSE:ACT) filed an ANDA application with the FDA to manufacture ... If Actavis wins, it can make and market a drug that is less expensive than anyone else in ...
    04/24/2015 - 1:31 am | View Link
  • Highly anticipated weight-loss pill wins FDA approval
    The FDA initially rejected Vivus' drug in 2010 over concerns that it can cause birth defects if taken by pregnant women. The agency laid out a risk-management plan Tuesday specifically designed to minimize the chance of the women becoming pregnant while ...
    07/18/2012 - 3:26 am | View Link
  • Vivus Wins FDA Approval for Obesity Drug, After Long, Messy Day
    Vivus has been pushing for more than two years to get its new obesity drug cleared for sale by the FDA, and after one last long, confusing day, it finally got its wish. The FDA said today that the Mountain View, CA-based company (NASDAQ: VVUS) has gotten ...
    07/17/2012 - 12:35 pm | View Link
  • Second Diet Drug Wins FDA Approval
    In approving the drug, FDA signaled its intent that the drug's use be tightly controlled. For example, the drug's label will include a number of contraindications, and Vivus, the company that is marketing the drug, will be required to complete 10 ...
    07/16/2012 - 9:00 pm | View Link
  • Vivus Wins FDA Approval
    MINYANVILLE ORIGINAL Vivus (VVUS) shareholders got a piece of good news late last week when the Food and Drug Administration approved the ... a decision on market clearance in April but the FDA delayed doing so until July 17. "The majority of the value ...
    04/30/2012 - 12:40 pm | View Link
  • More
BING SEARCH:
  • VIVUS, Inc. (VVUS) News Headlines
    VIVUS, Inc. (VVUS) News – Find the latest company news headlines for VIVUS, Inc. and all the companies you research at NASDAQ.com
    04/25/2015 - 3:32 am | View Website
  • Vivus
    View detailed financial information, real-time news, videos, quotes and analysis on Vivus (NASDAQ:VVUS). Explore commentary on Vivus and hear what the experts at ...
    04/24/2015 - 8:44 pm | View Website
  • BioWorld | The Daily Biopharmaceutical News Source
    Contains business, science, and regulatory news, including mergers and collaborations, FDA hearings and results, and research breakthroughs. Need subscription to use.
    04/24/2015 - 3:08 pm | View Website
  • Vivus' Suit Against Actavis Gets Some Dates
    Vivus (NASDAQ:VVUS) is in a litigation battle with Actavis (NYSE:ACT) with regard to the anti-obesity drug Qsymia. Last year Actavis filed an application with the FDA ...
    03/6/2015 - 10:22 pm | View Website
  • The Newest FDA-Approved Obesity Drug Is Also the Oldest
    Novo Nordisk gains FDA approval for Saxenda, which is already approved as an obesity treatment called Victoza. - Brian Orelli - Health Care
    12/27/2014 - 7:59 am | View Website
  • More
Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More U.s. News